Dynavax Expands Commercial and Clinical Leadership
January 12, 2010 06:00 ET
|
Dynavax Technologies Corporation
BERKELEY, CA--(Marketwire - January 12, 2010) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today the addition of two new senior executives to direct
key commercial and clinical...
Dynavax Completes Symphony Dynamo Acquisition
January 04, 2010 06:00 ET
|
Dynavax Technologies Corporation
BERKELEY, CA--(Marketwire - January 4, 2010) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that stockholders approved the acquisition of
Symphony Dynamo, Inc. (SDI), including...
Die Fertigungsanlage in Europa von Dynavax erhält Zulassung für die kommerzielle Produktion des Hepatitis-B-Oberflächenantigens für HEPLISAV
December 09, 2009 11:03 ET
|
Dynavax Technologies
BERKELEY, KALIFORNIERN und DÜSSELDORF, DEUTSCHLAND--(Marketwire - December 9, 2009) -
Dynavax Technologies Corporation (NASDAQ: DVAX) gab heute bekannt, dass die GMP-Fertigungsanlage in...
Dynavax's European Manufacturing Facility Approved for Commercial Production of HEPLISAV Hepatitis B Surface Antigen
December 09, 2009 01:00 ET
|
Dynavax Technologies
BERKELEY, CA and DUSSELDORF, GERMANY--(Marketwire - December 9, 2009) - Dynavax Technologies
Corporation (NASDAQ: DVAX) announced today that its GMP manufacturing
facility in Düsseldorf, Germany...
Dynavax Completes Enrollment of First Cohort of Patients in Phase 1b Clinical Trial for Hepatitis B Therapy
November 19, 2009 06:45 ET
|
Dynavax Technologies
BERKELEY, CA--(Marketwire - November 19, 2009) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that enrollment has been completed for the first of
three cohorts of patients...
Dynavax to Acquire Symphony Dynamo, Inc., Including $20 Million in Unrestricted Cash
November 10, 2009 06:45 ET
|
Dynavax Technologies
BERKELEY, CA--(Marketwire - November 10, 2009) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it has exercised its option to purchase all of
the equity of Symphony Dynamo,...